Filing Details

Accession Number:
0001140361-15-034926
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-11 20:08:36
Reporting Period:
2015-09-09
Filing Date:
2015-09-11
Accepted Time:
2015-09-11 20:08:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070698 Raptor Pharmaceutical Corp RPTP Pharmaceutical Preparations (2834) 860883978
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1517790 Louise Suzanne Bruhn C/O Raptor Pharmaceutical Corp.
7 Hamilton Landing, Suite 100
Novato CA 94949
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-09-09 45,000 $3.33 51,695 No 4 M Direct
Common Stock Acquisiton 2015-09-09 15,000 $5.13 66,695 No 4 M Direct
Common Stock Disposition 2015-09-09 18,258 $12.47 48,437 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock options (right to buy) Disposition 2015-09-09 45,000 $0.00 45,000 $3.33
Common Stock Stock options (right to buy) Disposition 2015-09-09 15,000 $0.00 15,000 $5.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-04-11 No 4 M Direct
0 2021-09-22 No 4 M Direct
Footnotes
  1. Includes 5021 Restricted Stock Units ("RSUs") granted on May 19, 2015. The Reporting Person is entitled to one (1) share of common stock for each one (1) RSU upon the vesting thereof. The RSUs vest in four equal quarterly installments with the final installment vesting no later than immediately prior to the 2016 annual meeting of stockholders.
  2. This transaction was executed in multiple trades at prices ranging from $12.36 to $12.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. Fully vested and exercisable.